Jessica Fye
Stock Analyst at J.P. Morgan
(4.37)
# 1,281
Out of 4,988 analysts
591
Total ratings
54.3%
Success rate
7.1%
Average return
Main Sectors:
Stocks Rated by Jessica Fye
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Reiterated: Buy | n/a | $236.72 | - | 51 | Sep 15, 2026 | |
| VRTX Vertex Pharmaceuticals | Initiated Coverage: Buy | $530 → $560 | $508.34 | +10.16% | 22 | Sep 11, 2026 | |
| AMRN Amarin Corporation | Initiated Coverage: Sell | $10 → $13 | $13.63 | -4.62% | 11 | Aug 21, 2026 | |
| EBS Emergent BioSolutions | Initiated Coverage: Sell | n/a | $6.80 | - | 14 | Aug 21, 2026 | |
| IMCR Immunocore Holdings | Initiated Coverage: Buy | $50 | $32.00 | +56.25% | 15 | Aug 21, 2026 | |
| MBX MBX Biosciences | Initiated Coverage: Buy | $88 | $62.91 | +39.88% | 4 | Aug 21, 2026 | |
| MRNA Moderna | Reiterated: Sell | $40 → $77 | $154.04 | -50.01% | 24 | Aug 21, 2026 | |
| NKTR Nektar Therapeutics | Initiated Coverage: Hold | $30 → $65 | $67.10 | -3.13% | 32 | Aug 21, 2026 | |
| STOK Stoke Therapeutics | Initiated Coverage: Buy | $25 → $40 | $28.43 | +40.70% | 18 | Aug 21, 2026 | |
| BNTX BioNTech SE | Reiterated: Hold | n/a | $96.06 | - | 32 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 | $21.88 | +50.82% | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $19.72 | +47.06% | 18 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $91.83 | +28.50% | 15 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $179 → $175 | $120.00 | +45.83% | 28 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $76 | $44.44 | +71.02% | 33 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $375 | $239.56 | +56.54% | 28 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $276 | $240.74 | +14.65% | 34 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $110 → $120 | $125.31 | -4.24% | 26 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $60 → $61 | $43.39 | +40.59% | 15 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $425 | $350.84 | +21.14% | 14 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $685 → $687 | $494.63 | +38.89% | 34 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $13 → $12 | $8.68 | +38.25% | 19 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $76 → $35 | $17.61 | +98.75% | 13 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 → $17 | $16.69 | +1.86% | 15 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $63.94 | - | 16 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $63 → $65 | $112.45 | -42.20% | 19 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $46.65 | - | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $14 | $26.57 | n/a | 4 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $5 | $2.05 | n/a | 12 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $19 | $1.63 | n/a | 4 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.7599 | n/a | 3 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $7 | $96.81 | n/a | 3 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $94 → $66 | $137.99 | n/a | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $10.11 | n/a | 3 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $95 | $12.20 | n/a | 4 | Feb 8, 2018 |
Ascendis Pharma
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $236.72
Upside: -
Vertex Pharmaceuticals
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $530 → $560
Current: $508.34
Upside: +10.16%
Amarin Corporation
Aug 21, 2026
Initiated Coverage: Sell
Price Target: $10 → $13
Current: $13.63
Upside: -4.62%
Emergent BioSolutions
Aug 21, 2026
Initiated Coverage: Sell
Price Target: n/a
Current: $6.80
Upside: -
Immunocore Holdings
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $32.00
Upside: +56.25%
MBX Biosciences
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $88
Current: $62.91
Upside: +39.88%
Moderna
Aug 21, 2026
Reiterated: Sell
Price Target: $40 → $77
Current: $154.04
Upside: -50.01%
Nektar Therapeutics
Aug 21, 2026
Initiated Coverage: Hold
Price Target: $30 → $65
Current: $67.10
Upside: -3.13%
Stoke Therapeutics
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $25 → $40
Current: $28.43
Upside: +40.70%
BioNTech SE
Aug 19, 2026
Reiterated: Hold
Price Target: n/a
Current: $96.06
Upside: -
Aug 14, 2026
Rated: Buy
Price Target: $33
Current: $21.88
Upside: +50.82%
Aug 11, 2026
Reiterated: Buy
Price Target: $29
Current: $19.72
Upside: +47.06%
Aug 11, 2026
Reiterated: Buy
Price Target: $118
Current: $91.83
Upside: +28.50%
Aug 10, 2026
Rated: Buy
Price Target: $179 → $175
Current: $120.00
Upside: +45.83%
Aug 10, 2026
Rated: Buy
Price Target: $76
Current: $44.44
Upside: +71.02%
Aug 4, 2026
Reiterated: Buy
Price Target: $375
Current: $239.56
Upside: +56.54%
Aug 4, 2026
Rated: Buy
Price Target: $276
Current: $240.74
Upside: +14.65%
Jul 30, 2026
Rated: Hold
Price Target: $110 → $120
Current: $125.31
Upside: -4.24%
Jul 29, 2026
Rated: Hold
Price Target: $60 → $61
Current: $43.39
Upside: +40.59%
Jul 23, 2026
Reiterated: Buy
Price Target: $425
Current: $350.84
Upside: +21.14%
Jul 23, 2026
Reiterated: Buy
Price Target: $685 → $687
Current: $494.63
Upside: +38.89%
Jul 13, 2026
Initiated Coverage: Hold
Price Target: $13 → $12
Current: $8.68
Upside: +38.25%
Jul 13, 2026
Initiated Coverage: Hold
Price Target: $76 → $35
Current: $17.61
Upside: +98.75%
Jul 13, 2026
Reiterated: Hold
Price Target: $23 → $17
Current: $16.69
Upside: +1.86%
Oct 27, 2025
Reiterated: Buy
Price Target: n/a
Current: $63.94
Upside: -
Oct 27, 2025
Reiterated: Hold
Price Target: $63 → $65
Current: $112.45
Upside: -42.20%
Oct 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $46.65
Upside: -
Jun 7, 2022
Reiterated: Hold
Price Target: $18 → $14
Current: $26.57
Upside: n/a
Apr 7, 2022
Reiterated: Hold
Price Target: $7 → $5
Current: $2.05
Upside: n/a
Mar 14, 2022
Reiterated: Buy
Price Target: $20 → $19
Current: $1.63
Upside: n/a
Aug 20, 2021
Downgraded: Sell
Price Target: n/a
Current: $0.7599
Upside: n/a
Aug 3, 2021
Downgraded: Hold
Price Target: $13 → $7
Current: $96.81
Upside: n/a
Apr 6, 2020
Reiterated: Hold
Price Target: $94 → $66
Current: $137.99
Upside: n/a
Mar 19, 2018
Downgraded: Sell
Price Target: n/a
Current: $10.11
Upside: n/a
Feb 8, 2018
Downgraded: Hold
Price Target: $32 → $95
Current: $12.20
Upside: n/a